Dr. Pilar Blancafort is currently an associate professor of Cancer Epigenetics at The University of Western Australia in Crawley, Australia. Her academic background involved undergraduate (Universitat de Barcelona, Spain) and graduate (Universite de Montreal, Canada) degrees in Biochemistry and Molecular Biology, followed by a post-doctoral fellowship with the Barbas laboratory at the Scripps Research Institute (La Jolla, USA). In 2005, she established her own laboratory at the University of North Carolina at Chapel Hill, as Assistant Professor and later as tenured Associate Professor in 2011. In 2012, Professor Blancafort moved her laboratory at the University of Western Australia. Her laboratory focuses on the development of (epi)genome editing and nanotechnology approaches to target cancers that are currently refractory to treatment and associated with poor outcomes, such as “triple negative breast cancers. She joined the Harry Perkins Institute of Medical Research in 2014. She hold’s a Cancer Council of Western Australia (CCWA) and Australian Research Council (ARC) Future Fellowship.